Clearmind Medicine Inc. Share Price Canadian Securities Exchange
Equities
CMND
CA1850534027
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 1.78M 2.44M 143M |
---|---|---|---|---|---|
Net income 2022 | -9M -12.3M -720M | Net income 2023 | -8M -10.94M -640M | EV / Sales 2022 | - |
Net cash position 2022 | 388K 530K 31.05M | Net cash position 2023 | 5.51M 7.54M 441M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.09
x | P/E ratio 2023 |
-0.09
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |